Company / Shareholders' Equity
AETHLON MEDICAL INC Shareholders' Equity History
FY2014-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$5.8M
FY2024
5-year range
$5.8M / $17.0M
FY2020-FY2024
Trend
-61.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 10 years, ranging from -$15M in FY2014 to $17M in FY2022.
Based on SEC 10-K filings.
$6M in FY2024 with a 3-year CAGR of -15.1%.
Declined from $17M to $6M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -15.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -15.1%, indicating a declining trend.
- In FY2024, shareholders' equity decreased 61.7% year-over-year.
- Peak shareholders' equity was recorded in FY2022.
- Lowest shareholders' equity in the period was in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $5.8M | -61.7% |
| FY2023 | $15.1M | -11.3% |
| FY2022 | $17.0M | +80.2% |
| FY2021 | $9.4M | +0.2% |
| FY2020 | $9.4M | +53.4% |
| FY2018 | $6.1M | +806.9% |
| FY2017 | $676.4K | -56.4% |
| FY2016 | $1.6M | +152.3% |
| FY2015 | $615.5K | +104.1% |
| FY2014 | -$14.9M | -60.8% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026